Keywords: Nycomed, Euran, Zenpep, Russia, Pancretic enzyme, Marketing deal

Nycomed to market Eurand’s Zenpep in Russia-CIS

Article | 13 January 2011

Fast-growing independent Swiss drugmaker Nycomed has entered into an exclusive commercialization, license and supply agreement with Eurand NV (Nasdaq: EURX) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Nycomed

Eurand

Go to company listing

Related Drugs

Zenpep

Go to drug listing